M
WGSWW

Murchinson’s GeneDx Holdings Warrant WGSWW Stock Holding History

Murchinson’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-73,190
Closed -$155K – 161
2021
Q3 		$155K Sell
73,190
-51,800
-41% -$170K 0.08% 74
2021
Q2 		$575K Buy
+124,990
New +$535K 0.21% 52

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Murchinson's WGSWW Position: Q4 2021 in Review

Murchinson sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2021, closing a stake of 73,190 shares — an estimated $155K sold.

Murchinson first reported a position in WGSWW in Q2 2021 and held it in 2 quarters. The position peaked at $575K in Q2 2021. 33 funds tracked by Wall St. Rank hold WGSWW as of Q4 2021.

  • Murchinson reported no remaining GeneDx Holdings Warrant position as of Q4 2021 after selling out during the quarter.
  • Murchinson sold 73,190 GeneDx Holdings Warrant shares in Q4 2021, an estimated $155K.
  • Murchinson first reported a position in GeneDx Holdings Warrant in Q2 2021 and held it in 2 quarters.
  • Murchinson's GeneDx Holdings Warrant position peaked at $575K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2021.

Based on Murchinson's 13F filing for Q4 2021, filed 14 Feb 2022.